HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Paul Winner Selected Research
Paul Winner Research Topics
Disease
31
Migraine Disorders (Migraine)
03/2022 - 01/2002
10
Headache (Headaches)
01/2017 - 01/2002
10
Pain (Aches)
07/2016 - 01/2002
4
Nausea
10/2006 - 01/2002
2
Headache Disorders (Headache Syndromes)
05/2011 - 11/2003
2
Dizziness (Lightheadedness)
03/2009 - 01/2002
2
Paresthesia (Dysesthesia)
03/2009 - 11/2005
2
Respiratory Tract Infections (Respiratory Tract Infection)
03/2009 - 11/2005
2
Sleepiness
11/2005 - 01/2002
2
Photophobia (Light Sensitivity)
11/2005 - 03/2003
2
Hyperacusis (Phonophobia)
11/2005 - 03/2003
1
Body Weight (Weight, Body)
04/2012
1
Injection Site Reaction
10/2006
1
Vomiting
11/2005
1
Anorexia
11/2005
1
Gastroenteritis
11/2005
1
Epilepsy (Aura)
11/2005
1
Tremor (Tremors)
06/2005
1
Weight Gain
06/2005
1
Asthma (Bronchial Asthma)
06/2005
1
Anxiety Disorders (Anxiety Disorder)
06/2005
1
Primary Headache Disorders
11/2003
1
Tension-Type Headache (Tension Headache)
11/2003
1
Fatigue
01/2002
1
Asthenia
01/2002
Drug/Important Bio-Agent (IBA)
8
Pain-Free
IBA
07/2016 - 03/2003
6
Tablets
IBA
01/2012 - 10/2003
6
Sumatriptan (Imigran)
FDA Link
Generic
10/2006 - 03/2003
5
rizatriptan (Maxalt)
FDA Link
04/2012 - 01/2002
4
Tryptamines (Triptans)
IBA
11/2017 - 07/2002
4
Nasal Sprays
IBA
07/2016 - 06/2005
4
Topiramate (Topamax)
FDA Link
Generic
01/2012 - 11/2005
3
erenumab
IBA
01/2020 - 01/2017
3
zolmitriptan (Zomig)
FDA Link
07/2016 - 01/2006
2
Sodium
IBA
04/2015 - 01/2007
2
sumatriptan-naproxen
FDA Link
04/2015 - 01/2007
2
eletriptan (Relpax)
FDA Link
04/2007 - 03/2003
2
Pharmaceutical Preparations
IBA
06/2005 - 07/2002
1
eptinezumab
IBA
03/2022
1
lasmiditan
IBA
01/2021
1
Dihydroergotamine (Agit)
FDA Link
Generic
01/2021
1
Opioid Analgesics (Opioids)
IBA
11/2017
1
Calcitonin Gene-Related Peptide
IBA
01/2017
1
Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)
IBA
01/2017
1
Monoclonal Antibodies
IBA
01/2017
1
A-factor (Streptomyces)
IBA
04/2012
1
Type A Botulinum Toxins (Botox)
FDA Link
10/2011
1
preempt
IBA
10/2011
1
amsonic acid (DAS)
IBA
05/2011
1
8-dehydroxythienamycin (NS 5)
IBA
02/2006
1
Ibuprofen (Motrin)
FDA Link
Generic
06/2005
1
Acetaminophen (Paracetamol)
FDA Link
Generic
06/2005
1
Botulinum Toxins (Botulinum Toxin)
IBA
11/2003
Therapy/Procedure
5
Therapeutics
01/2017 - 11/2003
5
Aftercare (After-Treatment)
07/2016 - 10/2003
2
Drug Therapy (Chemotherapy)
06/2005 - 11/2003
1
Intravenous Administration
01/2021
1
Contraindications
11/2003